Ovipauz L Tablet contains a combination of Ethinyl Estradiol (0.03 mg) and Levonorgestrel (0.15 mg), which are synthetic hormones used primarily for oral contraception. Ethinyl Estradiol is a synthetic estrogen, while Levonorgestrel is a synthetic progestogen; together, they work by inhibiting ovulation, altering the cervical mucus to prevent sperm penetration, and modifying the endometrial lining to reduce the likelihood of implantation. Ovipauz L is indicated for the prevention of pregnancy in women of reproductive age who seek reliable contraception. It may also be prescribed for the management of menstrual disorders such as dysmenorrhea, menorrhagia, and irregular menstrual cycles. The tablet should be taken orally once daily, preferably at the same time each day, following the prescribed regimen to ensure maximum efficacy. Patients with a history of thromboembolic disorders, uncontrolled hypertension, liver disease, or hormone-sensitive malignancies should use this medication with caution and under strict medical supervision. Common side effects may include nausea, breast tenderness, headache, and mood changes, which are generally mild and transient. It is essential to consult a healthcare professional before initiating therapy to evaluate contraindications and ensure appropriate use.